Source: Xenotransplantation. Conference titles: Joint Meeting of the International Xenotransplantation Association (IXA), the International Pancreas and Islet Transplant Association (IPITA), and the Cell Transplant Society (CTS). Unidade: IQ
Subjects: DIABETES MELLITUS, BIOQUÍMICA, TRANSPLANTE DE PÂNCREAS
ABNT
CAMPOS-LISBÔA, Ana Carolina Vale et al. Biodritin'trade-mark' microencapsulated human islets: potential use in transplantation therapy for type 1 diabetes mellitus. Xenotransplantation. Copenhagen: Instituto de Química, Universidade de São Paulo. . Acesso em: 18 out. 2024. , 2007APA
Campos-Lisbôa, A. C. V., Grazioli, G., Mares-Guia, T. R. dos, Goldberg, A. C., & Sogayar, M. C. (2007). Biodritin'trade-mark' microencapsulated human islets: potential use in transplantation therapy for type 1 diabetes mellitus. Xenotransplantation. Copenhagen: Instituto de Química, Universidade de São Paulo.NLM
Campos-Lisbôa ACV, Grazioli G, Mares-Guia TR dos, Goldberg AC, Sogayar MC. Biodritin'trade-mark' microencapsulated human islets: potential use in transplantation therapy for type 1 diabetes mellitus. Xenotransplantation. 2007 ; 14( 5): 549 res. PU2112.[citado 2024 out. 18 ]Vancouver
Campos-Lisbôa ACV, Grazioli G, Mares-Guia TR dos, Goldberg AC, Sogayar MC. Biodritin'trade-mark' microencapsulated human islets: potential use in transplantation therapy for type 1 diabetes mellitus. Xenotransplantation. 2007 ; 14( 5): 549 res. PU2112.[citado 2024 out. 18 ]